InsidersTradesSigma
SK바이오사이언스: management transactions · South Korea · DART (FSS)
DART:sk-b32be3KR·DART (FSS)Mcap 3780.6Bn€
Browse the full directors' dealings record of SK바이오사이언스, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Market capitalisation: €3,780.6bn. The latest transaction was filed on 27 March 2026 — Purchase. Among the most active insiders: SK케미칼. All data is accessible without an account.
2
Insider Decl.
0
Thresholds
€115,619
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
40550.00 €
Income statement
Revenue651.37 Bn€
Gross profit75.92 Bn€12% margin
Net income−57.42 Bn€-8.8% margin
Balance sheet & cash
Market cap3780.55 Bn€
Total debt469.99 Bn€
Free Cash Flow−157.87 Bn€
Last declaration on 27 March 2026
Declarations2 total
2 of 2 declarations